STUB1 and acute myeloid leukemia: Their results suggests that evolving de novo AML may sometimes have a prodrome with subtle but discernable clinical manifestations which we corroborated and extended by demonstrating that elevated RDW is a risk factor for incident cytopenia on the pathway from CHIP to MN.